TGI Announces CEO Samuel Epstein Leading Scientific Presentation Platform at Geological Association of America Northeastern Regional Meeting

CEO and Research Team Present 11 Technical Papers Advancing Geochemical Modeling, Geothermal Solutions, and Natural Hazard ...

Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatolog…

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...
The Manila Times

Alpha Tau Announces First-Ever Oral Presentation of Alpha DaRT® Pancreatic Cancer Data at Digestive Disease Week (DDW) 2026

Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ('Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy ...

NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

Data presented by Johnson & Johnson at the 2026 European Lung Cancer Conference PARIS and CAMBRIDGE, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company” ...

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at th…

Borrelia burgdorferi OspA human monoclonal antibody in development as a single-dose Lyme prophylactic Phase 1 study of ...
The Manila Times

Casino Group: Release of 2025 financial data estimates presentation

The Group has released the presentation of its 2025 unaudited financial data estimates (not yet approved by the Board of ...

Council hears presentation on possible data center

Over the coming weeks, we will be taking a deep dive into data centers, their impact, benefits and what having one in ...

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

Featured presentation highlights positive BroADen Phase 1b atopic dermatitis trial results supporting KT-621’s compelling oral profileParallel ...

Protagonist Therapeutics: Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of ...

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety profile in a once daily pill for moderate-to-severe plaque psoriasisResults furt ...

NBC SPORTS DELIVERS LARGEST MLB OPENING DAY AUDIENCE ON RECORD FOR MULTI-GAME PRESENTATION

Arizona Diamondbacks-Los Angeles Dodgers is Most-Watched MLB “Opening Day” Primetime Game since 2017 & Delivered Largest ...

Ascelia Pharma Announces Acceptance of Orviglance Data for Oral Presentation at the Annual Radiology Congress ESGAR 2026

MALMÖ, SE / ACCESS Newswire / March 27, 2026 / Ascelia Pharma (STO:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that an abstract with an ...
Las Vegas Sun

LEO Pharma Presents New 12-Month Real-World Data for Tralokinumab at AAD 2026

LEO Pharma A/S, a global leader in medical dermatology, today announced the presentation of new post-hoc analyses of 12‑month real‑world data from the TRACE study of tralokinumab, at the 2026 American ...